7 results
DEFM14A
AGIO
Agios Pharmaceuticals Inc
11 Feb 21
Proxy related to merger
4:19pm
and the safety and treatment of animals as promulgated by the FDA, published at 21 C.F.R. § 58, rules issued by the United States Department of Agriculture
PREM14A
AGIO
Agios Pharmaceuticals Inc
29 Jan 21
Preliminary proxy related to merger
4:22pm
, rules issued by the United States Department of Agriculture or the European Medicines Agency (the “EMA”) the governing the use of animals
DEFA14A
EX-2.1
AGIO
Agios Pharmaceuticals Inc
21 Dec 20
Additional proxy soliciting materials
9:17pm
of animals as promulgated by the FDA, published at 21 C.F.R. § 58, rules issued by the United States Department of Agriculture or the European Medicines
8-K
EX-2.1
AGIO
Agios Pharmaceuticals Inc
21 Dec 20
Entry into a Material Definitive Agreement
9:15pm
of animals as promulgated by the FDA, published at 21 C.F.R. § 58, rules issued by the United States Department of Agriculture or the European Medicines
8-K
EX-99.1
AGIO
Agios Pharmaceuticals Inc
8 Sep 20
Agios Appoints Jonathan Biller as Chief Financial Officer, Head of Legal and Corporate Affairs
4:09pm
to 2011 at Bunge Limited, a publicly traded agriculture and food company. Prior to Bunge, Mr. Biller held roles of increasing responsibility at Alcon
D
ri05l8nc8ie 0h2gr
22 Nov 11
$78M in equity, sold $78M, 19 investors
12:00am
D
4b1bb7f8bnong0j
26 Apr 10
$8.82M in equity, sold $8.82M, 1 investor
12:00am
- Prev
- 1
- Next